A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2017
At a glance
- Drugs AADvac 1 (Primary) ; Aluminium hydroxide
- Indications Primary progressive aphasia
- Focus Adverse reactions; Pharmacodynamics
- Acronyms AIDA
- Sponsors Axon Neuroscience
- 28 Aug 2017 Planned End Date changed from 1 Aug 2020 to 1 Jul 2020.
- 28 Aug 2017 Status changed from not yet recruiting to recruiting.
- 08 Jun 2017 New trial record